● Recruiting

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Condition: Nasopharyngeal Carcinoma · Sponsor: National Cancer Centre, Singapore

PhaseN/A

Planned participants1000

Who can joinAll sexes, 21 Years to 99 Years

Healthy volunteersNo

About this study

This is a prospective platform study that will investigate the outcomes of patients with locoregionally-advanced nasopharyngeal carcinoma (LA-NPC) or recurrent-metastatic nasopharyngeal carcinoma (RM-NPC) who are assigned to treatment arms of different chemotherapy sequencing and intensity based on their pre- and on-treatment plasma EBV DNA results.

This description comes directly from the study's public registry record.

Talk to the study team

Melvin Lee Kiang Chua, MBBS, FRCR, PhD, FAMS · 64368000 · melvin.chua.l.k@singhealth.com.sg

Always discuss trial participation with your own doctor first.

Locations (1)

National Cancer Centre Singapore

Singapore, Singapore

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05517135